This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Bayer recalls part of Gamimune N after tampering probe
Federal regulators probe possible tampering of at least 13 vials of Bayer Gamimune N an immune deficiency drug. Bayer recalls about 8000 vials nationwide with limited impact expected. FDA says it is investigating and has no reports of harmed patients. Tampering appeared after the North Carolina plant with two lots from one distributor. The company notes other lots are not affected and recalls followed prior concerns about cloudy vials.
MENTIONED IN THIS ARTICLE
San Francisco
Bayer Corp
Bayer
Food and Drug Administration
North Carolina
Michael Fournel
FDA
Steve Masiello
The
Office of Compliance and Bio
Fournel
Kansas City, Mo
Eli Lilly and Co
Bristol- Myers Squibb
Robert Courtney